Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Michael Fuller comments in Law 360 article, “More PTAB Fights Between Big Pharma Could Be Looming.”

July 19, 2017  | Michael L. Fuller

Partner Michael Fuller was quoted in, “More PTAB Fights Between Big Pharma Could Be Looming,” an article published in Law360.

Excerpt: Pharmaceutical firms like Pfizer Inc. are accustomed to having their patents for brand-name drugs challenged by generics makers at the Patent Trial and Appeal Board.

Read Full Article Here >> (subscription required)

Partner Michael Fuller comments in Law 360 article, “More PTAB Fights Between Big Pharma Could Be Looming.” Headshot

Michael L. Fuller
Partner
San Diego
mike.fuller@knobbe.com
858-707-4000

Related Links

Industries

News & Insights

Blog - Aerospace
Nov 2025
Aerospace IP Strategy in View of Recent U.S. Patent Office Updates
Aerospace technology companies often decide between patenting an innovation or keeping it as a trade secret. Typically, the analysis involves comparing the potential strength of patent protection that is likely...
Publications
Nov 2025
Jeremiah Helm and Sean Murray’s Discuss Extension of Printed Matter Doctrine in Law360 Column
In their latest Law360 column discussing noteworthy Federal Circuit cases, partners Jeremiah Helm and Sean Murray examine the recent decision in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., and how...
News
Oct 2025
Ted Cannon Quoted in IAM Article on USPTO Director Squires’ First Director Review Decision
In the IAM article “Squires Shakes Things Up at PTAB in First Director Review Grant,” Ted Cannon discussed USPTO Director John Squires’ decision that could have an impact on the role...